At the same time, employers have been cutting back on their coverage of the drugs
Keywords: GLP-1 receptor agonists, obesity, weight loss, non-diabetic patients, cardiovascular outcomes, cost-effectiveness Introduction Obesity is a chronic disease with high prevalence and associated comorbidities, making it a growing global concern [7] [8]
Here are some practical tips for improving hydration on semaglutide or tirzepatide
However, dehydration from gastrointestinal side effects could affect blood pressure, particularly in people taking multiple blood pressure medications
da Cruz
Whether Novo Nordisk or Sanofi decide to renew their efforts for a triple agonist , or other competitors decide to compete also remains to be seen